Milestone Pharmaceuticals Inc (NASDAQ: MIST) kicked off on Friday, down -2.48% from the previous trading day, before settling in for the closing price of $2.02. Over the past 52 weeks, MIST has traded in a range of $1.12-$2.75.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -36.67% over the last five years. While this was happening, its average annual earnings per share was recorded 54.82%. With a float of $50.45 million, this company’s outstanding shares have now reached $53.33 million.
The firm has a total of 47 workers. Let’s measure their productivity. In terms of profitability, gross margin is 167.51%, operating margin of 5034.09%, and the pretax margin is 4943.42%.
Milestone Pharmaceuticals Inc (MIST) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Milestone Pharmaceuticals Inc is 5.14%, while institutional ownership is 49.72%.
Milestone Pharmaceuticals Inc (MIST) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.82% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 26.29% during the next five years compared to -7.22% drop over the previous five years of trading.
Milestone Pharmaceuticals Inc (NASDAQ: MIST) Trading Performance Indicators
Take a look at Milestone Pharmaceuticals Inc’s (MIST) current performance indicators. Last quarter, stock had a quick ratio of 15.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.90, a number that is poised to hit -0.16 in the next quarter and is forecasted to reach -0.99 in one year’s time.
Technical Analysis of Milestone Pharmaceuticals Inc (MIST)
Analysing the last 5-days average volume posted by the [Milestone Pharmaceuticals Inc, MIST], we can find that recorded value of 0.92 million was better than the volume posted last year of 0.7 million. As of the previous 9 days, the stock’s Stochastic %D was 25.59%. Additionally, its Average True Range was 0.15.
During the past 100 days, Milestone Pharmaceuticals Inc’s (MIST) raw stochastic average was set at 42.22%, which indicates a significant increase from 22.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.56% in the past 14 days, which was higher than the 52.03% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.9534, while its 200-day Moving Average is $1.6302. Now, the first resistance to watch is $2.0367. This is followed by the second major resistance level at $2.1033. The third major resistance level sits at $2.1767. If the price goes on to break the first support level at $1.8967, it is likely to go to the next support level at $1.8233. Now, if the price goes above the second support level, the third support stands at $1.7567.
Milestone Pharmaceuticals Inc (NASDAQ: MIST) Key Stats
The company with the Market Capitalisation of 105.06 million has total of 53,328K Shares Outstanding. Its annual sales at the moment are 1,000 K in contrast with the sum of -59,690 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -9,440 K.
